Navigation Links
'The Global Urology Devices Market Will Be Worth $8.6bn by 2022' Says Visiongain Report

LONDON, November 5, 2012 /PRNewswire/ --

A new report by Visiongain, a London-based business information provider, predicts that the global market for urology devices will be worth $8.6bn by 2022. The market-generated sales of $4.4bn in 2011. Similar to other markets in the medical device industry, the urology device market remained under pressure in 2011 owing primarily to increased pricing pressures. However, the market was still able to expand, with growth being fuelled by a number of factors, including patient demographics and continued advancements in minimally invasive and non-invasive surgical technologies in the urology field. The market is currently comprised of innovative urology devices for the treatment of a wide range of disorders that include urinary incontinence, prostate cancer, benign prostatic hyperplasia and kidney stones.

Rodrigo Gutierrez Gamboa, healthcare industry analyst, says: "Patient demographics and a strong R&D pipeline will continue to drive growth across all segments of the urology devices market over the forecast period. There will be a sustained influx of innovative and cost-effective urology technologies in the coming years that will continue to offset economic pressures in key regional markets. Pricing pressures have led R&D investments to be primarily focused on developing cost-effective technologies with improved safety profiles and ones that are able to streamline procedures. Over the next decade, innovation will thus be completely focused on the ability to achieve excellent clinical outcomes".
Visiongain's research also suggests that the world urology devices market may benefit from globalisation. There has been a steady rise in healthcare spending and medical insurance cover in countries such as Brazil, Russia, India and China (BRIC nations), owing to their rapidly growing economies. As a result, a greater proportion of the patient population will now be able to afford the treatments available, which will further strengthen demand in this sector.

Visiongain predicts that this market will grow steadily to 2022. The future of the urology devices market appears promising and has significant potential for growth and investment with the increasing demand for safer and cost-effective therapies. This new report adds to visiongain's wide range of analytical reports in healthcare and other industry areas.

For sample pages and further information concerning the Visiongain report Urology Devices: World Market Outlook 2012-2022 please visit

For an executive summary please contact:
e-mail: Sara Peerun on
Tel: +44(0)20-7336-6100

Companies Listed

Allengers Medical Systems
American Medical Systems
Asahi Kasei Corporation
Augmenix Inc (US)
B.Braun Melsungen AG
Baxter International
Boston Scientific
C.R. Bard
Caldera Medical
Cook Medical
Dornier MedTech GmbH
Electro Medical Systems
EMK Kinetics
Endo Health Solutions
Endopharmaceutical Holdings
First Quality Enterprises
Fresenius Medical Care
Gen-Probe (US)
Gyne Ideas
Hologic Incorporated
Hunter Urology (UK)
Intuitive Surgical
Johnson & Johnson
Karl Storz
Kimberly-Clark Corporation
Kobayashi Pharmaceutical
Medical Service (Germany)
Medline Industries
Mpathy Medical Devices
Multicept (Denmark)
NeoTract (US)
Nihon Kohden
Olympus Medical Systems Corp
Ontex International
Richard Wolf GmbH
Storz Medical AG
Svenska Cellulosa Aktiebolaget SCA
TARIS Biomedical
Teleflex Incorporated
Varian Medical Systems
Xenolith Medical

Notes for Editors

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

If you are interested in a more detailed overview of this report, please send an e-mail to or call her on +44(0)207-336-6100

SOURCE Visiongain
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems Management to Present at Jefferies 2012 Global Healthcare Conference
2. Dr Prem Honored With Prestigious Leadership Award for his Contribution in Global Healthcare & Medical Tourism Industry
3. A Successful Launch of a New Oncology Product Requires Global Teams & Planning
4. Watson Announces Global Generics Management Team
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Global Market for Neurodegenerative Disorder Treatments to Reach $23.5 billion in 2017, Weakness Disorders Treatments Outpace Progressive Ataxia Treatments
7. Global IP Automation Market 2011 - 2015: MarketResearchReports.Biz
8. Global High Potency Active Pharmaceutical Ingredients (HPAPIs) Market is Expected to Reach USD 17.5 billion in 2018: Transparency Market Research
9. Global eClinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies: MarketResearchReports.Biz
10. Global Hospital Supplies Market to 2018 - Increasing Preference for Electro-mechanical Tables over Conventional Hydraulic Models to Drive Market Growth: MarketResearchReports.Biz
11. Global Neuromodulation Devices Market is Expected to Reach USD 7,072.6 Million in 2018: Transparency Market Research
Post Your Comments:
(Date:11/27/2015)... 26, 2015 ... the "2016 Global Tumor Marker Testing ... and Sales Segment Forecasts, Innovative Technologies, Instrumentation ... to their offering. --> ... "2016 Global Tumor Marker Testing Market: ...
(Date:11/26/2015)... Bajos, November 26, 2015 Un ... de Bremachlorin para el cáncer avanzado.   ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Cancer Research . --> Clinical Cancer Research ...
(Date:11/26/2015)... UTRECHT, the Netherlands , November 26, 2015 /PRNewswire/ ...   A new combination approach blends immunotherapy ... --> A new combination approach blends immunotherapy with ... A new combination approach blends immunotherapy with ... the Netherlands has found that immunotherapy ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... ... , ... Jobs in hospital medical laboratories and in the imaging field lead ... Aureus Medical Group . These fields, as well as travel nursing, ... healthcare jobs through the company’s website, , The leading healthcare staffing ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer ... classically-influenced trailer titles work with any font, giving users limitless opportunities to stylize ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast cancers found ... mammography, according to a study published online in the journal Radiology. Researchers said ... may necessitate a change in treatment. , Breast MRI is the most sensitive ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in ... on several models of traditional and far-infrared saunas. , For traditional saunas, ... the most traditional Finnish sauna wood, and Finnleo uses only European Grade A Nordic ...
Breaking Medicine News(10 mins):